BioArctic revenue and financials
kr 300.40Change from previous close: −0.27%Absolute change: −kr 0.80
In the fiscal year ended December 2025, BioArctic reported revenue of kr 2B (+676.80% year over year). Net income was kr 1.02B, a net margin of 51.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +676.80%
- 2025 vs 2024
- Net margin
- 51.1%
- 2024: -68.8%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total assets | 2,819 | 2,679 | 2,575 | 2,601 | 2,330 |
| Current assets | 2,677 | 2,597 | 2,487 | 2,508 | 2,235 |
| Cash and equivalents | 1,081 | 1,205 | 1,040 | 1,105 | 948 |
| Short-term investments | 909 | 830 | 1,150 | 777 | 968 |
| Net property, plant and equipment | 137 | 77.6 | 83.0 | 88.1 | 90.1 |
| Current liabilities | 671 | 397 | 521 | 600 | 259 |
| Accounts payable | — | — | 23.9 | — | — |
| Total debt | 90.6 | 40.7 | 44.1 | 46.6 | 49.0 |
| Total liabilities | 803 | 481 | 608 | 632 | 294 |
| Total equity (incl. minority) | 2,016 | 2,198 | 1,967 | 1,969 | 2,036 |
| Retained earnings | — | — | 1,351 | — | — |